Results from two phase III studies of bortezomib (BTZ) consolidation vs observation (OBS) post-transplant in patients (pts) with newly diagnosed multiple myeloma (NDMM).

ISSN
1527-7755
0732-183X
Date Issued
2015
Author(s)
Straka, Christian
Vogel, Martin
Kropff, Martin H.
Metzner, Bernd
Langer, Christian
Sayer, Herbert G.
Duerk, Heinz Albert
Wandt, Hannes
Bassermann, Florian
Gramatzki, Martin
Roesler, Wolf
Knop, Stefan
Wolf, Hans-Heinrich
Brugger, Wolfram
Engelhardt, Monika Martha
Fischer, Thomas
Einsele, Hermann